747 related articles for article (PubMed ID: 18462260)
21. Growth hormone and cardiac function.
Lombardi G; Di Somma C; Marzullo P; Cerbone G; Colao A
Ann Endocrinol (Paris); 2000 Feb; 61(1):16-21. PubMed ID: 10790587
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular involvement in patients affected by acromegaly: an appraisal.
Mosca S; Paolillo S; Colao A; Bossone E; Cittadini A; Iudice FL; Parente A; Conte S; Rengo G; Leosco D; Trimarco B; Filardi PP
Int J Cardiol; 2013 Sep; 167(5):1712-8. PubMed ID: 23219077
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide and the mediation of the hemodynamic effects of growth hormone in humans.
Böger RH
J Endocrinol Invest; 1999; 22(5 Suppl):75-81. PubMed ID: 10442575
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone and the heart.
Saccà L; Cittadini A; Fazio S
Endocr Rev; 1994 Oct; 15(5):555-73. PubMed ID: 7843068
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone and the cardiovascular system.
Palmeiro CR; Anand R; Dardi IK; Balasubramaniyam N; Schwarcz MD; Weiss IA
Cardiol Rev; 2012; 20(4):197-207. PubMed ID: 22314142
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular disease and risk factors: the role of growth hormone.
Isgaard J
Horm Res; 2004; 62 Suppl 4():31-8. PubMed ID: 15591764
[TBL] [Abstract][Full Text] [Related]
27. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
[TBL] [Abstract][Full Text] [Related]
28. The role of the GH/IGF-I axis for cardiac function and structure.
Isgaard J; Tivesten A; Friberg P; Bengtsson BA
Horm Metab Res; 1999; 31(2-3):50-4. PubMed ID: 10226781
[TBL] [Abstract][Full Text] [Related]
29. Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.
Bielohuby M; Roemmler J; Manolopoulou J; Johnsen I; Sawitzky M; Schopohl J; Reincke M; Wolf E; Hoeflich A; Bidlingmaier M
Exp Biol Med (Maywood); 2009 Aug; 234(8):1002-9. PubMed ID: 19491373
[TBL] [Abstract][Full Text] [Related]
30. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
Colao A; Di Somma C; Cuocolo A; Spinelli L; Acampa W; Spiezia S; Rota F; Savanelli MC; Lombardi G
J Clin Endocrinol Metab; 2005 Sep; 90(9):5146-55. PubMed ID: 15985481
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone deficiency (GHD) in adult thalassaemic patients.
Scacchi M; Danesi L; Cattaneo A; Valassi E; Pecori Giraldi F; Argento C; D'Angelo E; Mirra N; Carnelli V; Zanaboni L; Cappellini MD; Cavagnini F
Clin Endocrinol (Oxf); 2007 Nov; 67(5):790-5. PubMed ID: 17608814
[TBL] [Abstract][Full Text] [Related]
32. Associated hormonal decline in aging: is there a role for GH therapy in aging men?
Lombardi G; Di Somma C; Rota F; Colao A
J Endocrinol Invest; 2005; 28(3 Suppl):99-108. PubMed ID: 16042367
[TBL] [Abstract][Full Text] [Related]
33. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
[TBL] [Abstract][Full Text] [Related]
34. Reduced nitric oxide levels in acromegaly: cardiovascular implications.
Ronconi V; Giacchetti G; Mariniello B; Camilletti A; Mantero F; Boscaro M; Vignini A; Mazzanti L
Blood Press; 2005; 14(4):227-32. PubMed ID: 16126556
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone and the heart.
Colao A; Marzullo P; Di Somma C; Lombardi G
Clin Endocrinol (Oxf); 2001 Feb; 54(2):137-54. PubMed ID: 11207626
[TBL] [Abstract][Full Text] [Related]
36. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
Pincelli AI; Bragato R; Scacchi M; Branzi G; Osculati G; Viarengo R; Leonetti G; Cavagnini F
J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
[TBL] [Abstract][Full Text] [Related]
37. The influence of growth hormone therapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Sowinski J; Wysocki H
Int J Cardiol; 2005 May; 101(2):257-63. PubMed ID: 15882673
[TBL] [Abstract][Full Text] [Related]
38. The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells.
Devin JK; Young PP
Curr Opin Investig Drugs; 2008 Sep; 9(9):983-92. PubMed ID: 18729005
[TBL] [Abstract][Full Text] [Related]
39. Iron status and cardiovascular risk factors in patients with haemodialysis versus patients with ischaemic heart disease.
Cheng YC; Kuo WW; Wu CH; Shu WT; Kuo CH; Hwang JM; Hsu HH; Chen LM; Huang CY; Lee SD
Nephrology (Carlton); 2009 Feb; 14(1):65-9. PubMed ID: 19054334
[TBL] [Abstract][Full Text] [Related]
40. The critical parameters in GH excess.
Sheppard MC
J Endocrinol Invest; 2005; 28(5 Suppl):92-5. PubMed ID: 16114283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
